Achieving inclusivity for minorities in clinical trials; Why local knowledge is key for pharmacovigilance; EU vs US trends in ...

New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

The pharmaceutical industry is preparing for ‘major disruptions’ following US President Donald Trump’s announcement on ...

Czechia proposes changes that will better define the role of patient organisations when informing patients about therapeutic procedures without violating advertising regulations.

The company is dedicated to maintaining the highest quality and regulatory standards while supporting smooth global business ...